The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment: A 6-year follow-up study

American Journal of Alzheimer's Disease and other Dementias

Volumn 21, Issue 3, 2006, Pages 182-188

  Annerbo, Sylvia ^a   Wahlund, Lars Olof ^a   Lökk, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Homocysteine; MCI; MMSE; TSH

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; THYROTROPIN; THYROXINE;

AGE; AGED; AGING; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; COGNITIVE DEFECT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PREDICTION; RISK ASSESSMENT; RISK FACTOR;

EID: 33745889629     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317506289282     Document Type: Article

References (34)

1. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246.
2. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive stat of patients by the clinicians. J Psychiatry Res. 1975;12:189-198.
3. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
4. Wahlund LO, Pihlstrand E, Jonhagen ME. Mild cognitive impairment: experience from a memory clinic. Acta Neurol Scand Suppl. 2003;179:21-24.
5. Morris JC. Dementia update 2003. Alzheimer Dis Assoc Disord. 2003;17:245-258.
6. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;332:1447-1451.
7. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476-483.
8. 12 and folate in relation to the development of Alzheimer's disease. Neurology. 2001;56:1188-1194.
9. Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord. 1999;10:12-20.
10. 12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol. 1997;52A:76-79.
11. 12 and folate tissue deficiency markers amongst elderly Swedes: a population-based study. J Intern Med. 2001;249:423-432.
12. Stryer L. Biochemistry. 4th ed. New York, NY: W. H. Freeman; 1995.
13. Gottfries CG, Lehmann W, Regland B. Early diagnosis of cognitive impairment in the elderly with focus on Alzheimer's disease. J Neural Transm. 1998;105:773-786.
14. van Osch LA, Hogervorst E, Combrinck M, Smith AD. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology. 2004;62:1967-1971.
15. Volpato S, Guralnik JM, Fried LP, Remaley AT, Cappola AR, Launer LJ. Serum thyroxine level and cognitive decline in euthyroid older women. Neurology. 2002;58:1055-1061.
16. Prinz PN, Scanlan JM, Vitaliano PP, et al. Thyroid hormones: positive relationships with cognition in healthy, euthyroid older men. J Gerontol A Biol Sci Med Sci. 1999;54:M111-M116.
17. Kalmijn S, Metha KM, Pols HAP, Hofman A, Drexhage HA, Breteler MMB. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam Study. Clin Endocrinol (Oxf). 2000;53:733-737.
18. Colleran KM, Romero LR, Upton DA, Burge MR. Methimazole-induced hypothyroidism paradoxically decreases homocysteine. Metab Clin Exp. 2005;54:460-465.
19. Gottfris CG, Winblad B. Dementia diseases in aging: several risk factors for Alzheimer's disease. Lakartidningen. 1995;92:3017-3021.
20. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Publ Health. 1998;88:1337-1342.
21. Miller JW. Homocysteine and Alzheimer's disease. Nutr Rev. 1999;57:126-129.
22. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
23. Lopez O, Huff FJ, Martinez AJ, Bedetti CD. Prevalence of thyroid abnormalities is not increased in Alzheimer's disease. Neurobiol Aging. 1989;10:247-251.
24. Small GW, Matsuyama SS, Komanduri, R, Kumar V, Jarvik LF. Thyroid disease in patients with dementia of the Alzheimer type. J Am Geriatr Soc. 1985;33:538-539.
25. Luo L, Yano N, Mao Q, Jackson IM, Stopa EG. Thyrotrophic releasing hormone (TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis. 2002;4:97-103.
26. Perry EK. The cholinergic system in old age and Alzheimer's disease. Age Aging. 1980;9:1-8.
27. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000;132:270-278.
28. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002;137:904-914.
29. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the Third US National Health and Nutrition Examination Survey. Atherosclerosis. 2001;155:195-200.
30. Breteler MMB. Vascular risk for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000;21:153-160.
31. Daly E, Zaitchik D, Touchon J, et al. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol. 2000;57:675-680.
32. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:198-205.
33. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-765.
34. Sawin CT. Age-related changes in thyroid function. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000: 254-256.